NovoCure Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Haifa Israel (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2009
NCT00916409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

NovoCure Ltd.